News
News from us and our partners
News
News
Industrial Biotech
News
Capital
News
Digital Medicine
News
Sofinnova’s newest partners discuss their career paths
Sofinnova publishes 2023 Impact Report
Johnson & Johnson to acquire Shockwave Medical
Cure51 raises a €15 million seed round to harness the natural power of cancer survivors to develop first in class treatments and transform cancer into a curable disease
CEO spotlight: CinCor's Marc de Garidel
Tags
Topics
0 results
- News
Sofinnova Partners appoints two new partners, strengthening team of next generation investors
- News
Sitryx nominates SYX-5219 a novel, oral and targeted PKM2 activator for clinical development in atopic dermatitis
- News
Sensorion announces a €15 Million financing, extending cash runway until the end of 2025
- News
Johnson & Johnson to acquire Shockwave Medical
- News
Moon Surgical expands to gynecological surgery
- News
Asceneuron joins critical path for Alzheimer’s Disease Consortium
- News
Cure51 raises a €15 million seed round to harness the natural power of cancer survivors to develop first in class treatments and transform cancer into a curable disease
- News
Moon Surgical's Maestro System powered by NVIDIA Holoscan paves the way to next-generation laparoscopy, with over 200 patients treated
- News
Biotalys and Novonesis announce manufacturing and commercialisation partnership for EVOCA NG
- News
Sofinnova Partners portfolio company Amolyt Pharma to be acquired by AstraZeneca
- News
Amolyt Pharma enters into definitive agreement to be acquired by AstraZeneca
- News
Mission Therapeutics raises £25.2 million to progress clinical candidates in the area of mitophagy
- News
Sensorion announces it has met primary endpoint for SENS-401 Phase 2a Clinical Study for residual hearing preservation
- News
NodThera’s NLRP3 inhibitor NT-0796 reverses neuroinflammation in Parkinson’s disease phase Ib/IIa trial
- News
Signature of a partnership agreement with Kiro